Mavorixafor, sold under the brand name Xolremdi, is a medication used for the treatment of WHIM syndrome. It is a CXC chemokine receptor 4 antagonist...
9 KB (535 words) - 05:46, 6 October 2024
(INN) Masterone (Syntex) Matulane matuzumab (INN) mavacoxib (USAN) Mavik mavorixafor (INN) mavrilimumab (INN) Maxair (3M) redirects to pirbuterol Maxalt Maxaquin...
4 KB (270 words) - 04:44, 24 November 2024
potentially by increasing the CD8+ T-cells in the tumor microenvironment. Mavorixafor (Xolremdi) is a small-molecule drug that targets CXCR4 mutations, it...
3 KB (388 words) - 15:47, 30 April 2024
The molecular formula C21H27N5 may refer to: D75-4590 Mavorixafor This set index page lists chemical structure articles associated with the same molecular...
490 bytes (45 words) - 17:29, 4 January 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
10 KB (962 words) - 22:42, 28 August 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
14 KB (1,641 words) - 23:08, 5 September 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
97 KB (11,029 words) - 03:48, 27 October 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
67 KB (7,905 words) - 23:28, 11 December 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
20 KB (2,419 words) - 10:18, 3 November 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
30 KB (2,916 words) - 06:01, 2 December 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
21 KB (2,597 words) - 22:21, 12 October 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
9 KB (885 words) - 07:16, 30 April 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
19 KB (1,726 words) - 12:13, 3 December 2023
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
14 KB (1,728 words) - 16:03, 28 October 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
17 KB (1,685 words) - 07:47, 1 July 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
26 KB (2,934 words) - 23:08, 5 September 2024
plerixafor versus the current treatment of G-CSF in patients with WHIM. Mavorixafor (Xolremdi) is a small-molecule drug that targets CXCR4 mutations, it...
9 KB (1,013 words) - 15:45, 30 April 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
22 KB (2,660 words) - 15:08, 13 July 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
22 KB (2,644 words) - 07:23, 4 September 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
18 KB (2,001 words) - 20:34, 1 December 2023
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
9 KB (704 words) - 21:32, 3 September 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
24 KB (2,881 words) - 19:11, 20 November 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
11 KB (1,441 words) - 05:48, 2 November 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
23 KB (2,498 words) - 21:29, 27 March 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
20 KB (2,508 words) - 19:36, 5 September 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
4 KB (518 words) - 21:19, 21 November 2023
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
12 KB (954 words) - 13:32, 23 April 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
10 KB (930 words) - 21:55, 23 September 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
17 KB (2,039 words) - 03:19, 24 August 2024
(against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12) Ubiquitin Antagonists: Mavorixafor Plerixafor (AMD3100) Antibodies: Ulocuplumab (against CXCR4) CXCR5 Agonists:...
28 KB (3,133 words) - 05:49, 2 November 2024